Abstract
Previous research has found a correlation between resistin and lipid level variations. Polymorphisms in the resistin gene (RETN) could be involved in this relationship, but the results of the different studies are contradictory. The aim of this study was to examine the association between resistin and lipid levels, and to determine whether resistin polymorphisms are associated with resistin levels and lipid profile in prepubertal children and adolescents. The single nucleotide polymorphisms (SNPs) rs1862513 and rs10401670 were analyzed in 442 randomly selected 6- to 8-year-old children and 827 children aged 12–16 years. Anthropometric data were recorded. Lipid profile was determined using standard methods. Serum resistin levels were measured using a multiplexed bead immunoassay. Resistin polymorphisms were determined by TaqMan® allelic discrimination assays. A relationship was found between serum levels of resistin and the SNP rs10401670 in 6- to 8-year-old boys. SNP rs10401670 was also related to TC and LDL-cholesterol in 12- to 16-year-old boys and to HDL-C in 12- to 16-year-old girls. SNP rs1862513 was not related to any of the studied variables. Serum resistin levels were significantly and negatively associated with ApoAI levels in 12- to 16-year-old girls. A SNP in the 3′UTR region of RETN (rs10401670) is associated with resistin levels and lipid profile in children, showing different associations depending on age and gender.
Similar content being viewed by others
References
Szalowska E, Elferink MGL, Hoek A et al (2009) Resistin is more abundant in liver than adipose tissue and is not up-regulated by lipopolysaccharide. J ClinEndocrinolMetab 94:3051–3057
Steppan CM, Lazar MA (2004) The current biology of resistin. J Intern Med 255:439–447
Lee S, Kim HS (2012) Human resistin in cardiovascular disease. J Smooth Muscle Res 48:27–35
Owecki M, Nikisch E, Miczke A et al (2010) Serum resistin is related to plasma HDL cholesterol and inversely correlated with LDL cholesterol in diabetic and obese humans. Neuro Endocrinol Lett 31:673–678
Jové M, Planavila A, Cabrero A et al (2003) Reductions in plasma cholesterol levels after fenofibrate treatment are negatively correlated with resistin expression in human adipose tissue. Metabolism 52:351–355
Asano H, Izawa H, Nagata K et al (2010) Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. Diabetologia 53:234–246
Chen CC, Li TC, Li CI et al (2005) Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metabolism 54:471–475
Aquilante CL, Kosmiski LA, Knutsen SD et al (2008) Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults. Metabolism 57:494–501
de Luis DA, Gonzalez Sagrado M, Conde R et al (2009) Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients. Diabetes Res ClinPract 84:174–178
Norata GD, Ongari M, Garlaschelli K et al (2007) Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 156:279–284
Uslu S, Kebapçi N, Kara M et al (2012) Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus. Exp Ther Med 4:113–120
Roth CL, Kratz M, Ralston MM, Reinehr T (2011) Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children. Metabolism 60:445–452
Maggio AB, Wacker J, Montecucco F et al (2012) Serum resistin and inflammatory and endothelial activation markers in obese adolescents. J Pediatr 161:1022–1027
Gherlan I, Vladoiu S, Alexiu F et al (2012) Adipocytokine profile and insulin resistance in childhood obesity. Maedica (Buchar) 7:205–213
Rubin DA, McMurray RG, Hackney AC et al (2011) Relationship between cardiovascular risk factors and adipokines in adolescents. Horm Res Paediatr 76:123–129
Boyraz M, Cekmez F, Karaoglu A et al (2013) Relationship of adipokines (adiponectin, resistin and RBP4) with metabolic syndrome components in pubertal obese children. Biomark Med 7:423–428
Menzhagui C, Coco A, Salvemini L et al (2006) Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. J Clin Endocrinol Metab 91:2792–2795
Osawa H, Tabara Y, Kawamoto R et al (2007) Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C reactive protein in the Japanese general population. Diabetes Care 30:1501–1507
Cho YM, Youn B-S, Chung SS et al (2004) Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 47:559–565
Azuma K, Oguchi S, Matsubara Y et al (2004) Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. Horm Metab Res 36:564–570
Lau CH, Muniandy S (2011) Adiponectin and resistin gene polymorphisms in association with their respective adipokine levels. Ann Hum Genet 75:370–382
Ukkola O, Kunnari A, Kesäniemi YA (2008) Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors. Regul Pept 149:56–59
Hivert MF, Manning AK, McAteer JB et al (2009) Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study. Diabetes 58:750–756
EngertJC Vohl M-C, Williams SM et al (2002) 5´Flanking variants of resistin are associated with obesity. Diabetes 51:1629–1634
Conneely KN, Silander K, Scott LJ et al (2004) Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 47:1782–1788
Mattevi VS, Zembrzuski VM, Hutz MH (2004) A resistin gene polymorphism is associated with body mass index in women. Hum Genet 115:208–212
Kunnari A, Ukkola O, Kesäniemi YA (2005) Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients. Diabet Med 22:583–589
Beckers S, Peeters AV, Freitas FD et al (2008) Analysis of genetic variations in the resistin gene shows no associations with obesity in women. Obesity 16:905–907
Cieslak J, Skorczyk A, Stachowiak M et al (2011) Polymorphisms in 5´-flanking regions of genes encoding adiponectin, leptin, and resistin are not associated with obesity of Polish children and adolescents. Mol Biol Rep 38:1793–1798
Carrascosa A, Fernández JM, Fernández A et al (2008) Spanish cross-sectional growth study. Part II. Height, weight and body mass index values from birth to adulthood. An Pediatr (Barc) 68:552–559
Cole TJ, Bellizi CB, Flegal KM et al (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240–1243
Ortega L, Riestra P, Navarro P et al (2013) Resistin levels are related to fat mass, but not to body mass index in children. Peptides 49:49–52
BeckersS Zegers D, Van Camp JK et al (2013) Resistin polymorphisms show associations with obesity, but not with bone parameters in men: results from the Odense Androgen Study. Mol Biol Rep 40:2467–2472
Smith SR, Bai F, Charbonneau C et al (2003) A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52:1611–1618
Hasegawa G, Ohta M, Ichida Y et al (2005) Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity. Acta Diabetol 42:104–109
Tang NP, Wang LS, Yang L et al (2007) A polymorphism in the resistin gene promoter is related to increased C-reactive protein levels in patients with coronary artery disease. Clin Chem Lab Med 45:1471–1475
Boumaiza I, Omezzine A, Rejeb J et al (2012) Association between four resistin polymorphisms, obesity, and metabolic syndrome parameters in Tunisian volunteers. Genet Test Mol Biomarkers 16:1356–1362
Costandi J, Melone M, Zhao A et al (2011) Human resistin stimulates hepatic overproduction of atherogenic ApoB-containing lipoprotein particles by enhancing ApoB stability and impairing intracellular insulin signaling. Circ Res 108:727–742
Acknowledgments
The article is dedicated to the late Prof. Manuel de Oya as the warmest homage to his memory. Prof. de Oya designed the Four Province Study and the ideas reflected in our work can be traced back to his. This work was supported by a grant from the Fondo de Investigación Sanitaria (FIS 11/00344) and Biobank grant FEDER RD09/0076/00101. The contract of C Garcés is co-financed by the Fondo de Investigación Sanitaria. Lorena Ortega and Pilar Navarro are fellows of the Conchita Rábago Foundation. We thank Oliver Shaw for his revision of our manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is dedicated to the late Prof. Manuel de Oya, as the warmest homage to his memory.
Rights and permissions
About this article
Cite this article
Ortega, L., Navarro, P., Riestra, P. et al. Association of resistin polymorphisms with resistin levels and lipid profile in children. Mol Biol Rep 41, 7659–7664 (2014). https://doi.org/10.1007/s11033-014-3658-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-014-3658-8